Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2014-03-21 Capital/Financing Update
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
KARO BIO OFFENTLIGGÖR PROSPEKT GÄLLANDE FÖRETRÄDESEMISSIONEN
Capital/Financing Update Classification · 95% confidence The document is titled "KARO BIO OFFENTLIGGÖR PROSPEKT GÄLLANDE FÖRETRÄDESEMISSIONEN" (Karo Bio publishes prospectus regarding the rights issue). It explicitly states that the prospectus concerning the rights issue has been approved and registered by the Swedish Financial Supervisory Authority (Finansinspektionen) and is now publicly available. A rights issue (nyemission/företrädesemission) is a form of capital raising or financing activity. Since the document is an announcement that the prospectus (the detailed document) is published and provides links/instructions on how to obtain it, it fits the definition of a Capital/Financing Update (CAP) or, given the short length and focus on publication, potentially a Report Publication Announcement (RPA). However, the core subject is the financing event itself (rights issue prospectus). Given the specific nature of announcing a prospectus for a rights issue, 'Capital/Financing Update' (CAP) is the most precise classification for the underlying event being announced, although 'RPA' is also plausible under the 'MENU VS MEAL' rule if this were just a brief notice. Since the content heavily details the rights issue mechanics and the availability of the prospectus, CAP is chosen as the primary subject matter classification over the general publication announcement.
2014-03-21 Swedish
Beslut vid Karo Bios extra bolagsstämma den 17 mars 2014
AGM Information Classification · 99% confidence The document is titled "Beslut vid Karo Bios extra bolagsstämma den 17 mars 2014" (Decisions at Karo Bio's Extraordinary General Meeting on March 17, 2014). It details specific resolutions passed at a shareholder meeting, including changes to the articles of association and approval of two share issues (a rights issue and a directed issue). Since it reports the decisions made at a general meeting, it relates to shareholder voting outcomes. Although it details decisions, the context of reporting decisions from a general meeting strongly aligns with the scope of AGM-related materials or voting results. Given the options, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most precise fit for reporting the outcomes of a general meeting's votes, even though it also covers capital changes. The document is a formal announcement of meeting outcomes, not a presentation (AGM-R) or a general capital announcement (CAP) that lacks the meeting context.
2014-03-17 Swedish
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 99% confidence The document explicitly details a change in shareholding percentage for an entity ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension') concerning 'Karo Healthcare AB'. It lists the 'Before the transaction' and 'After the transaction' share quantities and percentages, and the 'Reason for major shareholding notification' is clearly indicated. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2014-03-17 English
KARO BIO TO BE AWARDED 1 MSEK FROM VINNOVA
Regulatory Filings Classification · 99% confidence The document is a short press release announcing that Karo Bio will receive a 1 MSEK grant from Vinnova for preclinical cancer drug development. It contains key highlights, quotes from the CEO, and background information on the involved entities. It is not a comprehensive financial report (like 10-K or IR), nor is it a transcript (CT) or a formal regulatory filing detailing insider trades (DIRS) or capital changes (CAP/SHA). Since it is an announcement of specific, non-financial operational news (a grant award), it fits best under the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS), as it is a general press release published according to Swedish market laws.
2014-03-17 English
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific holder (Avanza Bank Holding AB for Avanza Pension) in Karo Healthcare AB. It explicitly states the 'Reason for major shareholding notification' and provides 'Before the transaction' and 'After the transaction' figures, culminating in a new percentage (10.07%). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2014-03-14 English
Audit Report / Information 2013
Audit Report / Information Classification · 98% confidence The document is titled "Årsredovisning" (Annual Report) in Swedish and contains a detailed table of contents listing sections like "Koncernens och moderbolagets resultaträkningar" (Group and parent company income statements), "Koncernens rapport över finansiell ställning" (Group statement of financial position), "Revisionsberättelse" (Auditor's Report), and a five-year financial overview ("Femårsöversikt"). This structure is characteristic of a comprehensive annual financial report. Although it also mentions the Annual General Meeting (ÅRSSTÄMMA) details, the primary and most extensive content is the full annual financial review and management discussion, which aligns best with the definition of an Annual Report (10-K, although this is a Swedish equivalent, the scope matches 10-K more than a quarterly report (IR) or a simple earnings release (ER)). The length (over 200,000 characters) confirms it is a full report, not just an announcement (RPA/RNS). FY 2013
2014-03-14 Swedish

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.